Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 7 hours ago
Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Date of authorisation: 19/06/2026, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Redemplo, plozasiran, Date of authorisation: 19/06/2026, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Redemplo, plozasiran, Date of authorisation...
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 21, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 4, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation...
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 15, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 7, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation...